Researchers at Ichilov Hospital in Tel Aviv say that they have developed a drug that appears to cure serious coronavirus cases, Kan News reported.
The drug, EXO-CD24, was administered to 30 moderately to severely ill coronavirus patients and 29 of them showed a marked improvement within two days and were released from the hospital three to five days later. The 30th patient also recovered but her recovery took several more days.
The drug fights the cytokine storm – a life-threatening immune response during which the body starts to attack its own cells – which scientists believe is fueling many coronavirus deaths. Cytokines are part of the body’s normal immune response to infection but their sudden release in large quantities can cause multisystem organ failure and death.
The inexpensive drug was developed by Professor Nadir Arber of the hospital’s Integrated Cancer Prevention Center. “The medicine is administered through inhalation, once a day, in a procedure that takes only a few minutes, for five days,” Arber said.
The researchers have successfully completed phase 1 trials and are now seeking approval from the Health Ministry to proceed with more advanced clinical trials.
Researchers at Hadassah Medical Center in Jerusalem also recently reported on a possible cure for severe coronavirus cases, which have already shown excellent results in Phase 2 trials.
The drug Allocetra, developed by the Israeli company Enlivex Therapeutics, also targets the cytokine storm caused by the coronavirus. It was administered to 16 virus patients at Hadassah – 9 in serious condition and 7 in critical condition.
After 28 days of treatment, all of the patients are still alive and 14 were released from the hospital an average of 5.3 days after receiving the medication.
Two patients remain on supplementary oxygen in intensive care.
(YWN Israel Desk – Jerusalem)
Join the official YWN WhatsApp status
5 Responses
Hold off on the vaccine. If these are succesful they very likely will be safer than the vaccine
Thank you for this important information.
HOWEVER… critically important, is to provide an accurate timeline when these remedies will actually be medically approved and available to the general population.
Your readers, many of whom are unfamiliar with the “Medical authorization process” may make a faulty and possibly fatal decision based on the assumption that the Covid 19 threat is almost over.
Has this been peer reviewed or is it like all other Israeli claims? Every other week we read about all of these medical miracles from Israel and they turn out to be wishful reporting.
Why are they not treating patients with other therapies until these new drugs are used?
Is there any reason why Monoclonal Antibodies are not being used for treatment in Israel? It is being used in the US with very good outcomes. Could it be that because Pfizer is studying the effectiveness of their vaccine on the Israeli population, treating Covid-19 patients successfully with the Antibodies would mess up the study?
I hope it works, but this study is weak. Why no control group?
Meanwhile, there is mounting evidence that Ivermectin is effective for COVID-19. Ivermectin is already being widely used in Latin America. (Ivermectin is a relatively safe, cheap, existing drug that was being used to treat parasites.)
Every single one of the dozens of studies done on Ivermectin to date is showing that Ivermectin works well for COVID-19. Although none of these studies were perfect, strong, consistent results tends to hold up after further scrutiny, and they should, because that is the definition of high probability (calculated using magnitude and consistency).
Some doctors are still unsure if the evidence is convincing. Other doctors, including many who have a successful track record of making new medical discoveries, such as Nobel prize winning Dr. Borody, and a former surgeon general of the United States, believe that the evidence is good enough for now. The risk is minimal. The benefits may be huge.
Ask your doctor if he has seen the studies on Ivermectin. You might save lives.